Gilead Sciences, Inc. (NASDAQ:GILD)

CAPS Rating: 4 out of 5

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Recs

0
Player Avatar StockDocStan (< 20) Submitted: 9/9/2011 10:50:44 AM : Outperform Start Price: $38.38 GILD Score: +5.60

Just wait until the quad pill is approved, and (finally) the other acquisitions start to show a diversifying pipeline!

Featured Broker Partners


Advertisement